Skip to main content
Firefly Neuroscience, Inc. (AIFF)
NASDAQ: AIFF · Real-Time Price · USD
3.090
+0.090 (3.00%)
At close: Apr 17, 2025, 4:00 PM
3.090
0.00 (0.00%)
After-hours: Apr 17, 2025, 7:43 PM EDT

Firefly Neuroscience Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.110.5-0.03
Revenue Growth (YoY)
-78.31%---
Gross Profit
0.110.5-0.03
Selling, General & Admin
7.332.842.071.76
Research & Development
1.950.741.32.93
Operating Expenses
9.293.583.374.69
Operating Income
-9.18-3.08-3.37-4.65
Interest Expense
-0.07-0.02-0.44-0.14
Currency Exchange Gain (Loss)
0.010.04-0.13-
Other Non Operating Income (Expenses)
-0.330.460.01-0
EBT Excluding Unusual Items
-9.57-2.6-3.93-4.79
Gain (Loss) on Sale of Investments
---0.55
Gain (Loss) on Sale of Assets
-0.01-0.170.31
Asset Writedown
-0.87--0.08-
Other Unusual Items
---0.06-0.45
Pretax Income
-10.46-2.6-3.9-4.38
Income Tax Expense
00--
Net Income
-10.46-2.6-3.9-4.38
Net Income to Common
-10.46-2.6-3.9-4.38
Shares Outstanding (Basic)
731-
Shares Outstanding (Diluted)
731-
Shares Change (YoY)
102.48%134.29%--
EPS (Basic)
-1.60-0.81-2.83-
EPS (Diluted)
-1.60-0.81-2.83-
Free Cash Flow
-6.3-2.17-2.89-3.82
Free Cash Flow Per Share
-0.96-0.67-2.10-
Gross Margin
100.00%100.00%-100.00%
Operating Margin
-8500.00%-618.07%--14543.75%
Profit Margin
-9685.18%-522.69%--13690.63%
Free Cash Flow Margin
-5836.11%-436.14%--11937.50%
EBITDA
-9.17-3.06-3.35-4.23
D&A For EBITDA
0.010.010.010.43
EBIT
-9.18-3.08-3.37-4.65
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q